China's Simcere Beats Out Eisai In Iguratimod Approval For Rheumatoid Arthritis

SHANGHAI- China's State FDA cleared Simcere Pharmaceutical Group's new drug application for Iremod (iguratimod) for rheumatoid arthritis, in the world's first approval of the compound, Simcere announced Aug. 25